Reply to Hodges et al. Comment on “Kura et al. Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United States. <i>Vaccines</i> 2026, <i>14</i>, 411”
- DOI
- 10.3390/vaccines14090759
- Published
- 08
- Container
- Vaccines
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/vaccines14090759,
title = {Reply to Hodges et al. Comment on “Kura et al. Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United States. <i>Vaccines</i> 2026, <i>14</i>, 411”},
author = {Klodeta Kura and John C. Lang and Dawei Wang and Yoonyoung Choi and Michelle G. Goveia and Anushua Sinha and Yao-Hsuan Chen and Elamin H. Elbasha},
year = {2026},
journal = {Vaccines},
doi = {10.3390/vaccines14090759},
url = {https://doi.org/10.3390/vaccines14090759}
}RIS
TY - JOUR TI - Reply to Hodges et al. Comment on “Kura et al. Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United States. <i>Vaccines</i> 2026, <i>14</i>, 411” AU - Klodeta Kura AU - John C. Lang AU - Dawei Wang AU - Yoonyoung Choi AU - Michelle G. Goveia AU - Anushua Sinha AU - Yao-Hsuan Chen AU - Elamin H. Elbasha PY - 2026 JO - Vaccines DO - 10.3390/vaccines14090759 UR - https://doi.org/10.3390/vaccines14090759 ER -
APA
Kura, K., Lang, J. C., Wang, D., Choi, Y., Goveia, M. G., Sinha, A., Chen, Y., & Elbasha, E. H. (2026). Reply to Hodges et al. Comment on “Kura et al. Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United States. <i>Vaccines</i> 2026, <i>14</i>, 411”. Vaccines. https://doi.org/10.3390/vaccines14090759
Source records
- doaj · retrieved 2026-09-26T14:57:33.619Z